EPISODE · Mar 30, 2026
Ep. 002 — The FDA Is Moving the Goalposts on Clinical AI
from Vitals & Signals
The FDA is quietly rewriting the fundamental contract of clinical AI regulation — moving from a pre-market permission slip to a post-market surveillance regime — and every founder, investor, and clinician in this industry needs to understand what that means before the framework lands.
NOW PLAYING
Ep. 002 — The FDA Is Moving the Goalposts on Clinical AI
No transcript for this episode yet
Similar Episodes
Jul 3, 2026 ·60m
Jun 26, 2026 ·51m
Jun 19, 2026 ·45m
Jun 12, 2026 ·62m
Jun 10, 2026 ·36m